Purchase Order 75N91020P00525

<p>The National Cancer Institute awarded a purchase order to Illumina, Inc. for $12,130.80, with an award date of June 15, 2020 and ultimate completion date of June 20, 2021. Work is performed in San Diego, California. The order is for service agreement items on a firm fixed price basis with no set-aside applied.</p>

<p>The National Cancer Institute awarded a purchase order to Illumina, Inc. for $16,085.00 on April 30, 2019, with a completion date of April 30, 2020. The order covers a maintenance agreement for sequencing equipment, performed in San Diego, California. No set-aside applied to this acquisition.</p>

<p>The National Cancer Institute awarded a purchase order to Illumina, Inc. for $4,066.13 on December 4, 2017, with a completion date of January 31, 2018. The order covers a maintenance agreement for Illumina sequencing equipment. Work is performed in San Diego, California. The purchase order carries firm fixed price terms and no set-aside designation.</p>

<p>The National Cancer Institute awarded a purchase order to Illumina, Inc. for $16,085.00 on May 17, 2019, with ultimate completion on June 14, 2020. Performance occurs in Bethesda, Maryland. The order is a firm fixed price service agreement with no set-aside applied.</p>

<p>The National Cancer Institute awarded a purchase order to Illumina, Inc. valued at $20,283.34 on April 24, 2020, for a service agreement with a firm fixed price. Work is performed in Bethesda, Maryland. The order is set to complete by July 19, 2020.</p>

<p>The National Cancer Institute awarded a purchase order to Illumina, Inc., valued at $24,738.00, on July 25, 2017, for software and hardware services, with an ultimate completion date of July 24, 2018. Work is performed in San Diego, California. The order is priced on a firm fixed price basis with no set-aside used.</p>

<p>The National Cancer Institute issued a purchase order to Illumina, Inc. for $17,675.00 on July 31, 2019, with ultimate completion on July 31, 2020. The order covers a maintenance agreement for DNA and RNA sequencing equipment, with work performed in San Diego, California. Pricing is firm fixed price with no set-aside applied.</p>

<p>The National Cancer Institute awarded a purchase order to Illumina, Inc. for $20,198.50 in scientific equipment, effective February 9, 2021, with completion targeted March 31, 2021. Performance occurs in San Diego, California. The order is firm fixed-price with no set-aside designation.</p>

<p>The National Cancer Institute awarded a purchase order to Illumina, Inc. valued at $12,560.00 on February 22, 2021, for a service agreement with a firm fixed price structure and no set-aside designation. Performance is located in Bethesda, Maryland, with an ultimate completion date of April 30, 2021.</p>

<p>The National Cancer Institute awarded a purchase order to Illumina, Inc. for $14,250 on August 2, 2019, for a preventative maintenance plan with firm fixed pricing and an ultimate completion date of February 20, 2020. Work is performed in San Diego, California. No set-aside was used.</p>